Sponsor or institution
Clinical trials and research at Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
As of November 12, 2026, Find a Trial lists 33 clinical trials run by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano that are recruiting, at sites in 19 countries (most in Italy (32), Germany (3), Spain (3)). By phase: Phase 2 (4), Phase 1/2 (2), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 33Clinical trials
- 19Countries
Newest trials
All recruiting trials (33)
-
Matching tumor and blood gene tests for HPV-negative head and neck cancer
This project will try to see if a simple blood test can show the same tumor gene patterns as tissue samples in people with HPV-negative head and neck cancer.
-
Multi-omics analysis of progression and tumor biology in head and neck adenoid cystic carcinoma
We will test whether different tumor biology types in people with metastatic head and neck adenoid cystic carcinoma explain why some cancers grow slowly while others grow faster.
-
Immune profile of people with desmoid-type fibromatosis
This project will test whether immune and inflammatory signals in tumors and blood can explain why some people with sporadic desmoid-type fibromatosis get better on their own or after systemic treatment.
-
Multidisciplinary palliative care pathway tailored to frailty for outpatient advanced cancer patients
This study will test whether a structured outpatient palliative care pathway that uses patient-reported symptom scores to tailor care can reduce symptoms and improve care experience for adults with advanced cancer and frailty.
-
Using a patient's oral microbiota to guide radiotherapy for head and neck cancer
We will test whether profiling the oral microbiota before radiotherapy can help predict and reduce side effects and improve treatment response for adults with head and neck cancer.
-
Classifying duodenal polyps in familial adenomatous polyposis
This project will test two risk models to see if they better predict dangerous duodenal polyps and cancer risk in people with genetically confirmed FAP.
-
Radiology-based prediction of HER2 level and T‑DXd benefit in metastatic breast cancer
This study tests whether patterns in CT or FDG‑PET images can show HER2 level and help predict response to trastuzumab deruxtecan for people with metastatic breast cancer.
-
Liver transplantation for patients with advanced bile duct cancer
This study is testing if liver transplantation can help patients with advanced bile duct cancer who have controlled their disease with treatment.
-
Skipping surgery or radiotherapy for some women with HER2-positive or triple-negative early breast cancer
This trial tests whether women with early HER2-positive or triple-negative breast cancer who have an excellent response to neoadjuvant therapy can safely skip surgery or skip radiotherapy.
-
Liver transplantation for patients with advanced bile duct cancer after treatment
This study is testing if liver transplantation can help patients with advanced bile duct cancer who have managed to control their tumors with treatment.
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
-
Neoadjuvant treatment for patients with advanced Pseudomyxoma peritonei
This study is testing a new combination of medications to see if it can help patients with advanced Pseudomyxoma peritonei have better surgery results.
-
Assessing a genomic classifier for HER2-positive early-stage breast cancer management
This study is testing a new genetic tool to see if it can help predict how well women with early-stage HER2-positive breast cancer will do after treatment with certain therapies.
-
Using Akynzeo to prevent nausea in endometrial cancer patients undergoing chemotherapy
This study is testing if a new combination of anti-nausea medication can help women with endometrial cancer avoid nausea and vomiting during their first round of chemotherapy.
-
Observational study on Epithelioid Haemangioendothelioma
This study is trying to learn more about Epithelioid Haemangioendothelioma, a rare type of cancer, by collecting information on how it behaves and how well different treatments work.
-
HPV vaccination after treatment for cervical dysplasia
This study tests whether getting the HPV vaccine after treatment for cervical dysplasia can help prevent the return of HPV-related issues in women.
-
Combining Niraparib and Abemaciclib for Advanced Ovarian Cancer Treatment
This study is testing a new combination of two drugs, niraparib and abemaciclib, to see if it can help women with advanced ovarian cancer who have already tried other treatments.
-
Registry for Epithelioid Hemangioendothelioma
This study is collecting information from people newly diagnosed with epithelioid hemangioendothelioma to better understand the disease and how it’s treated.
-
Investigating heart damage from thoracic radiotherapy in lung cancer patients
This study is testing how radiation treatment for lung cancer affects heart health in patients to help make treatments safer and more effective.
-
Observational study on CAR-T therapy for lymphoma in Italy
This study looks at how well CAR-T therapy works and its side effects for people with lymphoma in Italy by tracking their health over three years.
-
Pembrolizumab plus enfortumab vedotin for collecting duct and renal medullary carcinoma
This trial will test whether giving pembrolizumab together with enfortumab vedotin can shrink or control advanced or metastatic collecting duct carcinoma and renal medullary carcinoma in adults.
-
Treatment approaches for HPV-related lesions in women
This study looks at whether getting vaccinated after surgery for HPV-related lesions can help reduce the chances of women developing cervical dysplasia or cancer later on.
-
Combination treatment for metastatic hormone-sensitive prostate cancer
This study is testing whether adding local treatment like radiation or surgery to a hormone therapy for prostate cancer helps patients live longer without their cancer getting worse.
-
Personalizing cancer therapy by measuring immune suppression
This study is testing whether measuring certain immune cells in cancer patients can help tailor their treatments and understand how feelings of isolation might affect their immune system.
-
Building a national network for lung cancer treatment in Italy
This study is trying to create a nationwide network in Italy to gather information and improve treatments for advanced lung cancer patients using new therapies like immunotherapy.
-
Integrative platform for personalized lung cancer care using AI
This study is trying to create a smart tool that helps doctors predict how well immunotherapy will work for people with non-small cell lung cancer, so they can make better treatment choices.
-
Registry for rare head and neck cancers in Europe
This study is collecting information on rare head and neck cancers to better understand them and improve treatment and care for patients across Europe.
-
Preventing thyroid problems in children undergoing radiation therapy for cancer
This study is testing if giving a thyroid medication to children with cancer who are getting radiation therapy can help prevent thyroid problems later on.
-
Preoperative treatment for locally advanced rectal cancer using capecitabine and temozolomide
This study is testing if a combination of capecitabine and temozolomide, along with radiation, can help patients with locally advanced rectal cancer shrink their tumors before surgery.
-
Online program to support breast cancer patients with lifestyle changes
This study is testing an online program to help breast cancer survivors in Italy make healthy lifestyle changes to see if it can improve their chances of staying well and feeling better.
-
FOLFOXIRI plus temozolomide and bevacizumab for MGMT‑silenced, microsatellite‑stable metastatic colorectal cancer
This trial tests whether adding temozolomide to a FOLFOXIRI plus bevacizumab regimen helps people whose metastatic colorectal cancer is MGMT‑silenced and microsatellite‑stable.
-
Examining the impact of small-volume lymph node disease in endometrial and cervical cancer
This study is trying to see how small amounts of cancer in lymph nodes affect treatment choices and outcomes for people with early-stage endometrial and cervical cancer.
-
International registry for patients with retroperitoneal sarcoma
This study is collecting information and samples from patients with retroperitoneal sarcoma who have surgery to see how well different treatments work and how they affect survival.
Quick answers
How many clinical trials run by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano are recruiting right now?
33, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in Italy (32 trials), Germany (3 trials), Spain (3 trials), France (2 trials), Poland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 2, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.